Cargando…
Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial
Mass azithromycin distribution reduces all-cause childhood mortality in some high-mortality settings in sub-Saharan Africa. Although the greatest benefits have been shown in children 1 to 5 months old living in areas with high mortality rates, no evidence of a benefit was found of neonatal azithromy...
Autores principales: | Sié, Ali, Bountogo, Mamadou, Zakane, Alphonse, Compaoré, Guillaume, Ouedraogo, Thierry, Lebas, Elodie, Nyatigo, Fanice, Hu, Huiyu, Brogdon, Jessica, Arnold, Benjamin F., Lietman, Thomas M., Oldenburg, Catherine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768279/ https://www.ncbi.nlm.nih.gov/pubmed/36343592 http://dx.doi.org/10.4269/ajtmh.22-0245 |
Ejemplares similares
-
Neonatal azithromycin administration for prevention of infant
mortality
por: Oldenburg, Catherine E., et al.
Publicado: (2022) -
Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: A subgroup analysis of a randomized controlled trial
por: Bountogo, Mamadou, et al.
Publicado: (2023) -
Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
por: Sie, Ali, et al.
Publicado: (2023) -
Antenatal care attendance and risk of low birthweight in Burkina Faso: a cross-sectional study
por: Bountogo, Mamadou, et al.
Publicado: (2021) -
Influence of maternal age on birth and infant outcomes at 6 months: a cohort study with quantitative bias analysis
por: Gebreegziabher, Elisabeth, et al.
Publicado: (2023)